Genetic instabilities in human cancers
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Whether and how human tumours are genetically unstable has been debated for decades. There is now evidence that most cancers may indeed be genetically unstable, but that the instability exists at two distinct levels. In a small subset of tumours, the instability is observed at the nucleotide level and results in base substitutions or deletions or insertions of a few nucleotides. In most other cancers, the instability is observed at the chromosome level, resulting in losses and gains of whole chromosomes or large portions thereof. Recognition and comparison of these instabilities are leading to new insights into tumour pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic defects such as DNA mismatch repair deficiencies (dMMR) and microsatellite instability (MSI) predispose tumor cells to the accumulation of somatic mutations and are associated with increased TMB (Lengauer et al., 1998) and increased susceptibility to ICB (Le et al., 2017).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Lengauer et al., 1998
Citations
Cites
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,039
Cited by
Items 201–300 of 1,009
Meiners, S., Eickelberg, O., & Königshoff, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00186914 · Cited by 340
Babu, J. R., Jeganathan, K. B., Baker, D. J., Wu, X., Kang-Decker, N., & van Deursen, J. M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211048 · Cited by 339
“Abnormalities of chromosome number are a hallmark of the vast majority of human cancers, but little is known about the genetic events that can initiate or promote losses or gains of whole chromosomes (Hartwell and Kastan, 1994; Lengauer et al., 1998; Cahill et al., 1999b).”
BackgroundIntegral role of Noxa in p53-mediated apoptotic response
Shibue, T., Takeda, K., Oda, E., Tanaka, H., Murasawa, H., Takaoka, A., Morishita, Y., Akira, S., Taniguchi, T., & Tanaka, N. (2003) · Genes & Development · doi:10.1101/gad.1103603 · Cited by 338
Pathway-based personalized analysis of cancer
Drier, Y., Sheffer, M., & Domany, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219651110 · Cited by 337
“CIN tumors (85% of colon cancers) exhibit abnormal numbers of chromosomes, deletions and ampli fi cations of smaller genomic regions, and translocations, and tend to have p53 mutations (29, 30).”
BackgroundChromosomal variation in neurons of the developing and adult mammalian nervous system
Rehen, S. K., McConnell, M. J., Kaushal, D., Kingsbury, M. A., Yang, A. H., & Chun, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231487398 · Cited by 335
Eukaryotic DNA methylation as an evolutionary device
Colot, V., & Rossignol, J.-L. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199905)21:5<402::aid-bies7>3.0.co;2-b · Cited by 333
Genetics of hepatocellular carcinoma
Annick Buendia, M. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0319 · Cited by 329
Microenvironment-induced cancer metastasis
Rofstad, E. K. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138259 · Cited by 329
Tumor Invasion: Role of Growth Factor-Induced Cell Motility
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61023-4 · Cited by 330
Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability
Hermsen, M., Postma, C., Baak, J., Weiss, M., Rapallo, A., Sciutto, A., Roemen, G., Arends, J., Williams, R., Giaretti, W., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36051 · Cited by 328
“Concerning the molecular pathways underlying tumor progression, we know that genetic changes lead to the disruption of critical biologic functions and that they arise as a consequence of genomic instability, which in sporadic colorectal cancer occurs mainly at the chromosomal level [3].”
BackgroundMyung, K., Datta, A., & Kolodner, R. D. (2001) · Cell · doi:10.1016/s0092-8674(01)00227-6 · Cited by 327
Metabolic origins of spatial organization in the tumor microenvironment
Carmona-Fontaine, C., Deforet, M., Akkari, L., Thompson, C. B., Joyce, J. A., & Xavier, J. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700600114 · Cited by 323
“Biochim Biophys Acta Rev Canc 1805(1):105–117.”
Genomic instability — the engine of tumorigenesis?
Sieber, O. M., Heinimann, K., & Tomlinson, I. P. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1170 · Cited by 324
“Most cancers accumulate numerous genetic changes at the level of the nucleotide, gene and/or chromosom”
BackgroundIdentification of RFC(Ctf18p, Ctf8p, Dcc1p)
Mayer, M. L., Gygi, S. P., Aebersold, R., & Hieter, P. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00254-4 · Cited by 323
Evolution in Health and Disease
(2007) · doi:10.1093/acprof:oso/9780199207466.001.0001 · Cited by 320
Tutt, A., Gabriel, A., Bertwistle, D., Connor, F., Paterson, H., Peacock, J., Ross, G., & Ashworth, A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80479-5 · Cited by 321
Constitutional Aneuploidy in the Normal Human Brain
Rehen, S. K., Yung, Y. C., McCreight, M. P., Kaushal, D., Yang, A. H., Almeida, B. S. V., Kingsbury, M. A., Cabral, K. M. S., McConnell, M. J., Anliker, B., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4560-04.2005 · Cited by 319
“, 2001), including cases in which certain non-neuronal aneuploid cells in the brains of normal patients may, under appropriate conditions, contribute to brain tumorigenesis (Lengauer et al., 1998).”
BackgroundThe evolution of tumour phylogenetics: principles and practice
Schwartz, R., & Schäffer, A. A. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.170 · Cited by 318
“…as CNVs violate the model assumption that changes in distinct vari ant regions accumulate independently; instead, CNVs accumulate at multiple scales, from localized genescale variants to variation at the scale of large chromosome segments, whole chromosomes or even wholegenome ploidy 17,74,159 .”
BackgroundElevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells
Janssen, A., Kops, G. J. P. L., & Medema, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904343106 · Cited by 313
“Although an intriguing hypothesis and a clear causative link in experimental animal models [reviewed in (8)], it has never been shown that compromised checkpoint signaling directly underlies CIN in malignant human tissue or cultured human tumor cells (9, 10).”
BackgroundInfluentialIdentification and Characterization of Sa/Scc3p Subunits in the Xenopus and Human Cohesin Complexes
Losada, A., Yokochi, T., Kobayashi, R., & Hirano, T. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.3.405 · Cited by 317
“Malfunction in any one of these processes would result in chromosome missegregation and aneuploidy, potentially contributing to birth defects or tumor development (for reviews see Hassold and Jacobs, 1984; Lengauer et al., 1998).”
BackgroundImmortal Human Pancreatic Duct Epithelial Cell Lines with Near Normal Genotype and Phenotype
Ouyang, H., Mou, L.-J., Luk, C., Liu, N., Karaskova, J., Squire, J., & Tsao, M.-S. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64800-6 · Cited by 313
“In contrast to microsatellite instability which is a recessive trait and is caused by defects in mismatch repair genes resulting in genomic losses at the nucleotide sequence level, chromosomal instability seems to be a dominant phenotype that is consistently associated with the loss of spindle checkpoint control.(44,4…”
BackgroundCatto, J. W. F., Azzouzi, A.-R., Rehman, I., Feeley, K. M., Cross, S. S., Amira, N., Fromont, G., Sibony, M., Cussenot, O., Meuth, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.163 · Cited by 316
GENETIC AND EPIGENETIC ALTERATIONS IN COLON CANCER
Grady, W. M., & Markowitz, S. D. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103043 · Cited by 316
Mouse Model of Colonic Adenoma-Carcinoma Progression Based on Somatic Apc Inactivation
Hinoi, T., Akyol, A., Theisen, B. K., Ferguson, D. O., Greenson, J. K., Williams, B. O., Cho, K. R., & Fearon, E. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2735 · Cited by 314
“the initiation and/or progression of the majority of colorectal tumors in man (34).”
BackgroundThe human mitotic checkpoint protein BubR1 regulates chromosome–spindle attachments
Lampson, M. A., & Kapoor, T. M. (2005) · Nature Cell Biology · doi:10.1038/ncb1208 · Cited by 311
“BubR1 staining is apparent in control (A, D) but not BubR1depleted (B-C, E-F) cells, both cytoplasmic and on kinetochores, shown in insets (1-3).”
BackgroundInfluentialMultifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes
Greenberg, R. A., Sobhian, B., Pathania, S., Cantor, S. B., Nakatani, Y., & Livingston, D. M. (2006) · Genes & Development · doi:10.1101/gad.1381306 · Cited by 308
“Testament to this relationship is the observation that a significant fraction of inherited cancer syndromes stem from germline mutations in DNA repair and checkpoint control genes (Lengauer et al. 1998; Vessey et al. 1999).”
BackgroundmicroRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells
Wang, P., Zou, F., Zhang, X., Li, H., Dulak, A., Tomko, R. J., Lazo, J. S., Wang, Z., Zhang, L., & Yu, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1996 · Cited by 308
“Our data provide a novel mechanism of how miR-21 could potentially contribute to tumorigenesis by compromising cell cycle progression and DNA damage–induced checkpoint function under those conditions, which can lead to chromosomal instability that promotes tumorigenesis (47).”
Identification of molecular apocrine breast tumours by microarray analysis
Farmer, P., Bonnefoi, H., Becette, V, Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., MacGrogan, G., Bergh, J., Cameron, D., Goldstein, D., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1122 · Cited by 307
A method for calling gains and losses in array CGH data
Wang, P., Kim, Y., Pollack, J., Narasimhan, B., & Tibshirani, R. (2005) · Biostatistics · doi:10.1093/biostatistics/kxh017 · Cited by 307
“Genomic DNA copy number alterations are key genetic events in the development and progression of human cancers (Lengauer et al., 1998).”
BackgroundBRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
Elstrodt, F., Hollestelle, A., Nagel, J. H. A., Gorin, M., Wasielewski, M., van den Ouweland, A., Merajver, S. D., Ethier, S. P., & Schutte, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2853 · Cited by 305
“Allelic losses at 17q are therefore often underestimated, as karyotype-based methods do not detect loss when the retained allele is amplified or reduplicated (6, 12).”
BackgroundTelomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis
Meeker, A. K., Hicks, J. L., Iacobuzio-Donahue, C. A., Montgomery, E. A., Westra, W. H., Chan, T. Y., Ronnett, B. M., & De Marzo, A. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0984-03 · Cited by 306
Marquard, A. M., Eklund, A. C., Joshi, T., Krzystanek, M., Favero, F., Wang, Z. C., Richardson, A. L., Silver, D. P., Szallasi, Z., & Birkbak, N. J. (2015) · Biomarker Research · doi:10.1186/s40364-015-0033-4 · Cited by 305
“One such biological characteristic is a defect in one of the DNA repair systems, which often leads to the accumulation of genomic damage, such as point mutations and short indels, as well as gross copy number aberrations, termed genomic scars, that may be gain or loss of large chromosomal regions, or even whole chromo…”
BackgroundOverexpression and Amplification of Aurora-A in Hepatocellular Carcinoma
Jeng, Y.-M., Peng, S.-Y., Lin, C.-Y., & Hsu, H.-C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1057-03 · Cited by 304
Amplification/Overexpression of a Mitotic Kinase Gene in Human Bladder Cancer
Sen, S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.17.1320 · Cited by 304
Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends
Stellwagen, A. E., Haimberger, Z. W., Veatch, J. R., & Gottschling, D. E. (2003) · Genes & Development · doi:10.1101/gad.1125903 · Cited by 302
“However, tumor cells must also cope with massive amounts of genomic instability (Lengauer et al. 1998).”
BackgroundNuclear Receptor Coregulators and Human Disease
Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 302
BRCA1-Dependent Ubiquitination of γ-Tubulin Regulates Centrosome Number
Starita, L. M., Machida, Y., Sankaran, S., Elias, J. E., Griffin, K., Schlegel, B. P., Gygi, S. P., & Parvin, J. D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8457-8466.2004 · Cited by 302
“BRCA1(1-1852) have one amino-terminal FLAG tag.”
BackgroundMethodInfluentialA role for common fragile site induction in amplification of human oncogenes
Hellman, A., Zlotorynski, E., Scherer, S. W., Cheung, J., Vincent, J. B., Smith, D. I., Trakhtenbrot, L., & Kerem, B. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00017-x · Cited by 300
“…lack of visual ladder-like structures in most human tumorsof general chromosomal instability that characterizes early stages of many cancer types (Lengauer et al., 1998), such as containing intrachromosomal amplifications probably reflects their late stage in the cancer progression, during which…”
BackgroundOverexpression and mistargeting of centromere protein-A in human primary colorectal cancer.
Tomonaga, T., Matsushita, K., Yamaguchi, S., 大橋, 建., Shimada, H., Ochiai, T., Yoda, K., & Nomura, F. (2003) · PubMed · Cited by 298
A Translational View of the Molecular Pathogenesis of Lung Cancer
Sato, M., Shames, D. S., Gazdar, A. F., & Minna, J. D. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000263718.69320.4c · Cited by 297
Impairment of replication fork progression mediates RNA polII transcription‐associated recombination
Prado, F., & Aguilera, A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600602 · Cited by 292
“The maintenance of genome integrity is essential to safeguard genetic information and to prevent the loss of cell fitness that is generally associated with cancer and a number of genetic disorders (Lengauer et al, 1998; Kolodner et al, 2002).”
BackgroundOta, T., Suto, S., Katayama, H. G., Han, Z.-B., Suzuki, F., Maeda, M., Tanino, M., Terada, Y., & Tatsuka, M. (2002) · PubMed · Cited by 346
Differentiation therapy of human cancer: basic science and clinical applications
Leszczyniecka, M., Roberts, T., Dent, P., Grant, S., & Fisher, P. B. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00132-2 · Cited by 292
Sampson, J. H., Archer, G. E., Mitchell, D. A., Heimberger, A. B., Herndon, J. E., Lally-Goss, D., McGehee-Norman, S., Paolino, A., Reardon, D. A., Friedman, A. H., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0124 · Cited by 287
“These mutations, however, usually arise randomly as a result of the genetic instability of tumors (4, 5).”
BackgroundSallmyr, A., Fan, J., & Rassool, F. V. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.036 · Cited by 285
Yang, S., Farraye, F. A., Mack, C., Posnik, O., & O’Brien, M. J. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000141404.56839.6a · Cited by 286
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
Kennedy, R. D., & D'Andrea, A. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4171 · Cited by 286
DNA Content as a Prognostic Marker in Patients with Oral Leukoplakia
Sudbø, J., Kildal, W., Risberg, B., Koppang, H. S., Danielsen, H. E., & Reith, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441702 · Cited by 285
RetractedTomonaga, T., Nagao, K., Kawasaki, Y., Furuya, K., Murakami, A., Morishita, J., Yuasa, T., Sutani, T., Kearsey, S. E., Uhlmann, F., et al. (2000) · Genes & Development · doi:10.1101/gad.832000 · Cited by 281
“SMC proteins are also essential for mitotic chromosome condensation (Sutani and Yanagida 1997; Kimura et al. 1997; Sutani et al. 1999) and sex chromosome dosage compensation (Lieb et al. 1998), and DNA repair 5These authors contributed equally to this work.”
BackgroundWhole genome DNA copy number changes identified by high density oligonucleotide arrays
Huang, J., Wei, W., Zhang, J., Liu, G., Bignell, G. R., Stratton, M. R., Futreal, P., Wooster, R., Jones, K. W., & Shapero, M. H. (2004) · Human Genomics · doi:10.1186/1479-7364-1-4-287 · Cited by 279
“The underlying progression of genetic events which transform a normal cell into a cancer cell is characterised by a shift from the diploid to aneuploid state.(1,2) As a result of genomic instability, cancer cells accumulate both random and causal alterations at multiple levels, from point mutations to wholechromosome…”
BackgroundBender, F. C., Reymond, M. A., Bron, C., & Quest, A. F. G. (2000) · PubMed · Cited by 321
The aneuploidy paradox: costs and benefits of an incorrect karyotype
Sheltzer, J. M., & Amon, A. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.07.003 · Cited by 277
Microfabricated bioprocessor for integrated nanoliter-scale Sanger DNA sequencing
Blazej, R. G., Kumaresan, P., & Mathies, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602476103 · Cited by 277
Karpf, A. R., & Matsui, S.-I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1961 · Cited by 276
“translocations, and/or gene amplifications (6).”
Molecular Pathogenesis of Osteosarcoma
Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 273
“The RecQ helicases are involved in maintaining genomic stability by functioning at the interface between DNA replication and recombination to repair damaged replication forks (Lengauer et al ., 1998; Chakraverty and Hickson, 1999; Bachrati and Hickson, 2003).”
Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.
Meeker, A. K., Hicks, J. L., Platz, E. A., March, G. E., Bennett, C., Delannoy, M. J., & Marzo, A. M. D. (2002) · PubMed · Cited by 316
Kelloff, G. J., Lippman, S. M., Dannenberg, A. J., Sigman, C. C., Pearce, H. L., Reid, B. J., Szabo, E., Jordan, V. C., Spitz, M. R., Mills, G. B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1104 · Cited by 270
The Role of Aneuploidy in Cancer Evolution
Sansregret, L., & Swanton, C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028373 · Cited by 266
“Multiple mechanisms have been described to account for the high rate of whole-chromosome segregation errors (wCIN) and structural aberrations (sCIN) in cancerand have been comprehensively discussed elsewhere (Lengauer et al. 1998; Ganem et al. 2007; Holland and Cleveland 2009; Burrell et al. 2013b; Duijf and Benezra 2…”
BackgroundYe, X., Franco, A. A., Santos, H., Nelson, D. M., Kaufman, P. D., & Adams, P. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00037-6 · Cited by 267
Foley, E. A., Maldonado, M., & Kapoor, T. M. (2011) · Nature Cell Biology · doi:10.1038/ncb2327 · Cited by 267
“Our data indicate that these mutations may increase the frequency of whole chromosome gain or loss, the most common form of chromosomal instability in human tumour”
BackgroundThe promise of cancer vaccines
Gilboa, E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1359 · Cited by 267
“Mutated self antigens result from somatic mutations in normal gene products, reflecting the genetic instability of tumour cell”
BackgroundCytokinesis defects and cancer
Lens, S. M. A., & Medema, R. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0084-6 · Cited by 264
Chromosomal instability and cytoskeletal defects in oral cancer cells
Saunders, W. S., Shuster, M., Huang, X., Gharaibeh, B., Enyenihi, A. H., Petersen, I., & Gollin, S. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.303 · Cited by 265
Li, A., Walling, J., Kotliarov, Y., Center, A., Steed, M. E., Ahn, S. J., Rosenblum, M., Mikkelsen, T., Zenklusen, J. C., & Fine, H. A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0280 · Cited by 264
“The resulting chromosomal copy number changes and loss of heterogeneity can lead to alteration of oncogene and tumor suppressor gene dosage (2-4).”
BackgroundTetraploidy and chromosomal instability are early events during cervical carcinogenesis
Olaharski, A. J., Sotelo, R., Solorza-Luna, G., Gonsebatt, M. E., Guzman, P., Mohar, A., & Eastmond, D. A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi218 · Cited by 263
“defined as chromosomal instability creating an environment where aneuploidy and cancer can develop [3, 4 ].”
BackgroundCaspase-3 Promotes Genetic Instability and Carcinogenesis
Liu, X., He, Y., Li, F., Huang, Q., Kato, T. A., Hall, R. P., & Li, C.-Y. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.003 · Cited by 263
“Chromosome instability is key characteristic of cancer cells (Lengauer et al., 1997, 1998).”
Mirabelli-Primdahl, L., Gryfe, R., Kim, H., Millar, A. H., Luceri, C., Dale, D., Holowaty, E. J., Bapat, B. V., Gallinger, S., & Redston, M. S. (1999) · PubMed · Cited by 259
F ROM Z EBRAFISH TO H UMAN: Modular Medical Models
Shin, J. T., & Fishman, M. C. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.031402.131506 · Cited by 261
The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity
Baer, R. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00269-6 · Cited by 260
Epigenetic lesions causing genetic lesions in human cancer
Esteller, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00303-8 · Cited by 258
“The cancer cell diers from a normal cell in its genotype [1].”
BackgroundInoue, T., Hiratsuka, M., Osaki, M., Yamada, H., Kishimoto, I., Yamaguchi, S., Nakano, S., Katoh, M., Ito, H., & Oshimura, M. (2007) · Oncogene · doi:10.1038/sj.onc.1209857 · Cited by 258
“In solid cancers, two major types of genetic instability have been described, based on the findings initially observed in colorectal cancer (Lengauer et al., 1998).”
BackgroundChromosomal instability and cancer: a complex relationship with therapeutic potential
Bakhoum, S. F., & Compton, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59954 · Cited by 255
“CIN is a hallmark of most solid tumors (4), and it has long been postulated that chromosome missegregation is an important mechanism of tumor adaptation (1, 3).”
Martin, J. W., Squire, J. A., & Zielenska, M. (2012) · Sarcoma · doi:10.1155/2012/627254 · Cited by 252
“CIN is the elevated rate of gain or loss of entire chromosomes or sections of chromosomes [16, 18], and it appears to be significant in the pathogenesis of osteosarcoma tumours, resulting in complicated structural and numerical aberrations and wide variability between cells [19].”
BackgroundDNA Hypomethylation and Ovarian Cancer Biology
Widschwendter, M., Jiang, G., Woods, C., Müller, H. M., Fiegl, H., Goebel, G., Marth, C., Müller-Holzner, E., Zeimet, A. G., Laird, P. W., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0238 · Cited by 254
“Genomic instability and DNA hypomethylation are observed often early during carcinogenesis (15, 44 ).”
BackgroundChromosome Cohesion, Condensation, and Separation
Hirano, T. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.115 · Cited by 253
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells
Russo, J., Hasan Lareef, M., Balogh, G., Guo, S., & Russo, I. H. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00390-x · Cited by 252
The rate at which asexual populations cross fitness valleys
Weissman, D. B., Desai, M. M., Fisher, D. S., & Feldman, M. W. (2009) · Theoretical Population Biology · doi:10.1016/j.tpb.2009.02.006 · Cited by 251
“Note that in principle our earlier results also allow us to consider the case where one of the possible mutations increases the mutation rates at the other loci, as for example is common for some forms of cancer, although we will not explicitly discuss this situation here (Lengauer et al., 1998).”
ResultRAPID EVOLUTIONARY ESCAPE BY LARGE POPULATIONS FROM LOCAL FITNESS PEAKS IS LIKELY IN NATURE
Weinreich, D. M., & Chao, L. (2005) · Evolution · doi:10.1111/j.0014-3820.2005.tb01769.x · Cited by 252
The history of the angiogenic switch concept
Ribatti, D., Nico, B., Crivellato, E., Roccaro, A. M., & Vacca, A. (2007) · Leukemia · doi:10.1038/sj.leu.2404402 · Cited by 250
The Apoptosome: Heart and Soul of the Cell Death Machine
Chinnaiyan, A. M. (1999) · Neoplasia · doi:10.1038/sj.neo.7900003 · Cited by 250
ZW10 links mitotic checkpoint signaling to the structural kinetochore
Kops, G. J. P. L., Kim, Y., Weaver, B. A. A., Mao, Y., McLeod, I., Yates, J. R., Tagaya, M., & Cleveland, D. W. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411118 · Cited by 249
“Most chromosome imbalances during development cause embryonic lethality, and chromosome instability has been associated with tumorigenesis (Lengauer et al., 1998; Cohen, 2002).”
BackgroundMutational Heterogeneity in Human Cancers: Origin and Consequences
Salk, J. J., Fox, E. J., & Loeb, L. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102113 · Cited by 249
Stochastic Tunnels in Evolutionary Dynamics
Iwasa, Y., Michor, F., & Nowak, M. A. (2004) · Genetics · doi:10.1534/genetics.166.3.1571 · Cited by 248
“In general, we are interested in the case where (Lengauer et al. 1998).”
BackgroundInfluentialGenomic integrity and the repair of double-strand DNA breaks
Pastink, A., Eeken, J. C. J., & Lohman, P. H. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00167-1 · Cited by 247
Aneuploidy and chromosomal instability in cancer: a jackpot to chaos
Giam, M., & Rancati, G. (2015) · Cell Division · doi:10.1186/s13008-015-0009-7 · Cited by 246
“Since the link between mutations increasing nucleotide instability and cancer predisposition has been well established [5], in this review we will focus on the more controversial role of CIN and its ‘by-product’ aneuploidy in cellular transformation and tumor progression.”
BackgroundBastian, B. C., Kashani–Sabet, M., Hamm, H., Godfrey, T. E., Moore, D. H., Bröcker, E.-B., LeBoit, P. E., & Pinkel, D. (2000) · PubMed · Cited by 245
Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids
Bolhaqueiro, A. C. F., Ponsioen, B., Bakker, B., Klaasen, S. J., Kucukkose, E., van Jaarsveld, R. H., Vivié, J., Verlaan-Klink, I., Hami, N., Spierings, D. C. J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0399-6 · Cited by 243
Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models
Huycke, M. M., & Gaskins, H. R. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900702 · Cited by 244
Telomeres, chromosome instability and cancer
Bailey, S. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl303 · Cited by 243
“Therefore, in view of increasing evidence implicating genomic instability in carcinogenesis (153,154), telomere loss is likely to be a significant contributing factor.”
BackgroundThe molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review)
Nguyen, H., & Duong, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8679 · Cited by 244
“This leads to karyotypic variability from cell to cell that consequently forms an aneuploidy, sub-karyotypic amplification, chromosomal rearrangement, and a high frequency of LOH at tumor suppressor gene loci (5,6).”
InfluentialSomatic mutations and aging: a re-evaluation
Vijg, J. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00202-x · Cited by 243
Culture‐independent analysis of the gut microbiota in colorectal cancer and polyposis
Scanlan, P. D., Shanahan, F., Clune, Y., Collins, J. K., O'Sullivan, G. C., O'Riordan, M., Holmes, E., Wang, Y., & Marchesi, J. R. (2008) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01503.x · Cited by 245
“The majority (~90%) of colorectal cancers arise sporadically in a time-dependent manner through adenomatous polyp formation with the activation of oncogenes such as K-ras (Lengauer et al., 1998) and inactivation of tumour suppressor genes such as APC and p53 (Hope et al.”
BackgroundGenetic Changes in Neoplasms Arising in Congenital Melanocytic Nevi
Bastian, B. C., Xiong, J., Frieden, I. J., Williams, M. L., Chou, P., Busam, K., Pinkel, D., & LeBoit, P. E. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64393-3 · Cited by 241
“Genomic instability is considered as a significant factor in the pathogenesis of cancer.(16) There are several patterns of genomic instability, which are reflections of different functional defects in the cancer cells.”
BackgroundLin, X., Tascilar, M., Lee, W.-H., Vles, W. J., Lee, B. H., Veeraswamy, R., Asgari, K., Freije, D., van Rees, B., Gage, W. R., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63028-3 · Cited by 241
DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome
Poulogiannis, G., Frayling, I. M., & Arends, M. J. (2010) · Histopathology · doi:10.1111/j.1365-2559.2009.03392.x · Cited by 241
“Both epidemiological(1) and in vitro(2) studies have shown that oncogenic transformation requires the accumulation of at least 6–12 mutational events, possibly more,(3,4) a process that is facilitated by some form of genetic instability.(5,6) Recent advances in highthroughput sequencing have also shown that mutations…”
BackgroundSen, S. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200001000-00014 · Cited by 239
Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines
Qin, T., Jelinek, J., Si, J., Shu, J., & Issa, J.-P. J. (2009) · Blood · doi:10.1182/blood-2008-02-140038 · Cited by 237
Evolution of Resistance During Clonal Expansion
Iwasa, Y., Nowak, M. A., & Michor, F. (2006) · Genetics · doi:10.1534/genetics.105.049791 · Cited by 233
“Therefore, cancer cell clones with genetic instability (Lengauer et al. 1998; Loeb 2001; Nowak et al. 2002) might have a larger probability of generating resistant cells not only because of increased mutation rates, but also due to increased apoptosis rates, as such cell clones are more likely to…”
BackgroundStress Alters Rates and Types of Loss of Heterozygosity in Candida albicans
Forche, A., Abbey, D., Pisithkul, T., Weinzierl, M. A., Ringstrom, T., Bruck, D., Petersen, K., & Berman, J. (2011) · mBio · doi:10.1128/mbio.00129-11 · Cited by 234
“For example, LOH is a prerequisite for the initiation and the development of cancer (5) via inactivation of tumor suppressor genes (two-hit hypothesis) (6); indeed, LOH has been associated with breast (7), skin (8), and colorectal (9) cancer.”
BackgroundLi, Y., Sun, X., LaMont, J. T., Pardee, A. B., & Li, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0538044100 · Cited by 231
Metadata
- Authors
- Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1998-12
- Volume
- 396
- Issue
- 6712
- Pages
- 643-649
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1544851750
- Cited by
- 4,168
- References
- 98
- Citations by year
- 2026: 18 · 2025: 44 · 2024: 56 · 2023: 74 · 2022: 83 · 2021: 91 · 2020: 92 · 2019: 90 · 2018: 99 · 2017: 106 · 2016: 113 · 2015: 136 · 2014: 145 · 2013: 156 · 2012: 183
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- genomic instability, carcinogenesis, chromosomal instability, microsatellite instability, base substitutions, chromosomal deletion, chromosomal gains, cancer genetics
- MeSH terms
- Chromosome Aberrations, Gene Amplification, Humans, Neoplasms, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.